Spiriva Not Associated with Strokes or Heart Attacks

A recent study released show that the inhaled medication Spiriva, used to treat patients with chronic obstructive pulmonary disease(COPD), is not associated with an increased risk of cardiovascular deaths. This announcement was made in response to another recent studypublished in the Annals of Internal Medicine, showing that ipratropium, another inhaled medication used to treat COPD and asthma, was associated with an increased risk of cardiovascular deaths in people with newly diagnosed COPD.

These reports follow a report by the Food and Drug Administration that Spiriva increases the risk of stroke in some people. This is the most recent report of many regarding concerns for side effects from medications used to treat asthma and COPD.

Learn more:

• Advair and Asthma Death
• Xolair and Anaphylaxis
• Singulair and Suicide